| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1791-1803, Copyright © 1995 by Endocrine Society
ARTICLES |
A Guiochon-Mantel, JF Savouret, F Quignon, K Delabre, E Milgrom and H De The
INSERM U-135 Hormones et Reproduction Hopital Bicetre.
PML (promyelocytic leukemia) is a protein involved in the t (15;17) translocation of promyelocytic leukemia and is mainly localized in nuclear bodies. Here we show that PML exerts a very powerful enhancing activity (up to 20-fold) on the transactivating properties of the progesterone receptor (PR) and has a similar effect on several other steroid hormone receptors. There is probably a direct or indirect interaction between PR and PML, because when the latter was expressed at high concentrations it shifted PR into the nuclear bodies. The use of deletion mutants showed that both activation functions (AF1 and AF2) of PR as well as the coiled coil and His-Cys-rich domains of PML were required for transcriptional enhancement. The fusion protein PML-RAR which is not localized in nuclear bodies, also enhanced the transactivating activity of PR, but this effect was totally suppressed by the administration of retinoic acid. PML, which is ubiquitously expressed, may thus be involved in the transactivation properties of steroid hormone receptors. This mechanism may also play a role in the oncogenic properties of PML-RAR and in their suppression by retinoic acid.
This article has been cited by other articles:
 |
|
 |
|
  R. L. Arnett-Mansfield, J. D. Graham, A. R. Hanson, P. A. Mote, A. Gompel, L. L. Scurr, N. Gava, A. de Fazio, and C. L. Clarke Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity Mol. Endocrinol., January 1, 2007; 21(1): 14 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Georgiakaki, N. Chabbert-Buffet, B. Dasen, G. Meduri, S. Wenk, L. Rajhi, L. Amazit, A. Chauchereau, C. W. Burger, L. J. Blok, et al. Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription Mol. Endocrinol., September 1, 2006; 20(9): 2122 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kurki, L. Latonen, and M. Laiho Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization J. Cell Sci., October 1, 2003; 116(19): 3917 - 3925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Amazit, Y. Alj, R. K. Tyagi, A. Chauchereau, H. Loosfelt, C. Pichon, J. Pantel, E. Foulon-Guinchard, P. Leclerc, E. Milgrom, et al. Subcellular Localization and Mechanisms of Nucleocytoplasmic Trafficking of Steroid Receptor Coactivator-1 J. Biol. Chem., August 22, 2003; 278(34): 32195 - 32203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Chee, P. Lopez, P. P. Pandolfi, and B. Roizman Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects J. Virol., June 15, 2003; 77(12): 7101 - 7105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-Y. Lin, M.-Z. Lai, D. K. Ann, and H.-M. Shih Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential J. Biol. Chem., April 25, 2003; 278(18): 15958 - 15965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lopez, R. J. Jacob, and B. Roizman Overexpression of Promyelocytic Leukemia Protein Precludes the Dispersal of ND10 Structures and Has No Effect on Accumulation of Infectious Herpes Simplex Virus 1 or Its Proteins J. Virol., August 12, 2002; 76(18): 9355 - 9367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fuchsova, P. Novak, J. Kafkova, and P. Hozak Nuclear DNA helicase II is recruited to IFN-{alpha}-activated transcription sites at PML nuclear bodies J. Cell Biol., August 5, 2002; 158(3): 463 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. B. Borden Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies Mol. Cell. Biol., August 1, 2002; 22(15): 5259 - 5269. [Full Text] [PDF]
|
|
|
|
|
|
W. V. Bonilla, D. D. Pinschewer, P. Klenerman, V. Rousson, M. Gaboli, P. P. Pandolfi, R. M. Zinkernagel, M. S. Salvato, and H. Hengartner Effects of Promyelocytic Leukemia Protein on Virus-Host Balance J. Virol., March 19, 2002; 76(8): 3810 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xu, J.-H. Ahn, M. Cheng, C. M. apRhys, C.-J. Chiou, J. Zong, M. J. Matunis, and G. S. Hayward Proteasome-Independent Disruption of PML Oncogenic Domains (PODs), but Not Covalent Modification by SUMO-1, Is Required for Human Cytomegalovirus Immediate-Early Protein IE1 To Inhibit PML-Mediated Transcriptional Repression J. Virol., November 15, 2001; 75(22): 10683 - 10695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lallemand-Breitenbach, J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P. P. Pandolfi, E. Puvion, P. Freemont, et al. Role of Promyelocytic Leukemia (PML) Sumolation in Nuclear Body Formation, 11S Proteasome Recruitment, and As2O3-induced PML or PML/Retinoic Acid Receptor {alpha} Degradation J. Exp. Med., June 11, 2001; 193(12): 1361 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-S. Wu, S. Vallian, E. Seto, W.-M. Yang, D. Edmondson, S. Roth, and K.-S. Chang The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases Mol. Cell. Biol., April 1, 2001; 21(7): 2259 - 2268. [Abstract] [Full Text]
|
|
|
|
|
|
J. Burkham, D. M. Coen, C. B. C. Hwang, and S. K. Weller Interactions of Herpes Simplex Virus Type 1 with ND10 and Recruitment of PML to Replication Compartments J. Virol., March 1, 2001; 75(5): 2353 - 2367. [Abstract] [Full Text]
|
|
|
|
|
|
S. Tsuzuki, M. Towatari, H. Saito, and T. Enver Potentiation of GATA-2 Activity through Interactions with the Promyelocytic Leukemia Protein (PML) and the t(15;17)-Generated PML-Retinoic Acid Receptor alpha Oncoprotein Mol. Cell. Biol., September 1, 2000; 20(17): 6276 - 6286. [Abstract] [Full Text]
|
|
|
|
|
|
A. Chauchereau, M. Georgiakaki, M. Perrin-Wolff, E. Milgrom, and H. Loosfelt JAB1 Interacts with Both the Progesterone Receptor and SRC-1 J. Biol. Chem., March 17, 2000; 275(12): 8540 - 8548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Szapary, Y. Huang, and S. S. Simons Jr. Opposing Effects of Corepressor and Coactivators in Determining the Dose-Response Curve of Agonists, and Residual Agonist Activity of Antagonists, for Glucocorticoid Receptor-Regulated Gene Expression Mol. Endocrinol., December 1, 1999; 13(12): 2108 - 2121. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Melnick and J. D. Licht Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Blood, May 15, 1999; 93(10): 3167 - 3215. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Doucas, M. Tini, D. A. Egan, and R. M. Evans Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling PNAS, March 16, 1999; 96(6): 2627 - 2632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Doucas and R. M. Evans Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling PNAS, March 16, 1999; 96(6): 2633 - 2638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vallian, K.-V. Chin, and K.-S. Chang The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter Mol. Cell. Biol., December 1, 1998; 18(12): 7147 - 7156. [Abstract] [Full Text]
|
|
|
|
|
|
J. Burkham, D. M. Coen, and S. K. Weller ND10 Protein PML Is Recruited to Herpes Simplex Virus Type 1 Prereplicative Sites and Replication Compartments in the Presence of Viral DNA Polymerase J. Virol., December 1, 1998; 72(12): 10100 - 10107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Taylor, J.-F. Savouret, C. Vaisse, J.-L. Vigne, I. Ryan, D. Hornung, M. Seppälä, and E. Milgrom Promegestone (R5020) and Mifepristone (RU486) Both Function as Progestational Agonists of Human Glycodelin Gene Expression in Isolated Human Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4006 - 4012. [Abstract] [Full Text]
|
|
|
|
|
|
C.-J. Chang, Y.-L. Chen, and S.-C. Lee Coactivator TIF1beta Interacts with Transcription Factor C/EBPbeta and Glucocorticoid Receptor To Induce alpha 1-Acid Glycoprotein Gene Expression Mol. Cell. Biol., October 1, 1998; 18(10): 5880 - 5887. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Moilanen, H. Poukka, U. Karvonen, M. Häkli, O. A. Jänne, and J. J. Palvimo Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription Mol. Cell. Biol., September 1, 1998; 18(9): 5128 - 5139. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Henry, X. Yuan, N. J. Koszewski, H. Onda, D. J. Kwiatkowski, and D. J. Noonan Tuberous Sclerosis Gene 2 Product Modulates Transcription Mediated by Steroid Hormone Receptor Family Members J. Biol. Chem., August 7, 1998; 273(32): 20535 - 20539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. LaMorte, J. A. Dyck, R. L. Ochs, and R. M. Evans Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body PNAS, April 28, 1998; 95(9): 4991 - 4996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alcalay, L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, and P. G. Pelicci The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein Mol. Cell. Biol., February 1, 1998; 18(2): 1084 - 1093. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. M. Koken, A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. S. Kabarowski, J. Zhu, S. Dong, S.-J. Chen, Z. Chen, et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies PNAS, September 16, 1997; 94(19): 10255 - 10260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Thenot, C. Henriquet, H. Rochefort, and V. Cavailles Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1 J. Biol. Chem., May 2, 1997; 272(18): 12062 - 12068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Chatterjee and R. A. Fisher Novel Alternative Splicing and Nuclear Localization of Human RGS12 Gene Products J. Biol. Chem., September 15, 2000; 275(38): 29660 - 29671. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
